Skip to content

CPRIT: Patient Adherence to Lung Cancer Screening

CPRIT: Patient Adherence to Lung Cancer Screening

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06872723
Enrollment
340
Registered
2025-03-12
Start date
2025-03-21
Completion date
2031-02-28
Last updated
2025-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer Screening

Brief summary

To understand participants' barriers to lung cancer screening and their experience with scheduling lung cancer screening.

Detailed description

Primary Objectives/Aims 1. Determine rates of lung cancer scheduling and screening at the UTMB and UT Tyler LCS programs. 2. Using state-of-the-art machine learning (ML) approaches, develop prediction models for adherence to screening guidelines for newly eligible and established patients. Investigators will leverage data from BRFSS, UT Tyler and UTMB to develop and validate the prediction model, ensuring its generalizability and accuracy. 3. Survey participants in the LCS programs about their impressions and experience with the scheduling and completing screening; conduct interviews with participants who receive an order for LCS but do not complete screening by their due date. 4. Interview LCS program directors and staff about barriers and facilitators of increasing screening rates in their programs.

Interventions

BEHAVIORALLung Cancer Screening

Participants who agree to take part in this study, will participate in an interview. During the interview, participants may be asked about: • Participants background information, such as your race and level of education • Participants lung cancer diagnosis and your history of lung cancer screening • Participants experience with scheduling lung cancer screening • Any barriers that kept participants from completing screening

Sponsors

M.D. Anderson Cancer Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Current smoker or quit within the past 15 years * A 20+ pack-year smoking history * Healthy enough for treatment

Exclusion criteria

* Not applicable as our focus is on patients with an order for screening at the UTMB or UT Tyler

Design outcomes

Primary

MeasureTime frame
Safety and Adverse Events (AEs)Through study completion; an average of 1 year.

Countries

United States

Contacts

Primary ContactRobert Volk, PHD
bvolk@mdanderson.org713-563-2509

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026